BEE-spoke-data/govdocs1-by-extension huggingface dataset:
QUESTIONS AND ANSWERS TO 1-155-SEB.1599

**Question 1**: What initial level of project management competency will
each of the 30 attendees have?

**Answer 1**: Single project development, Theory of constraints
concepts, single project management, ProChain use and concepts. Several
3-4 expert project managers and schedulers will be involved as noted.
They have multiple project management experience w/o using multi-project
software/concepts/management.

**Question 2**: How many training sessions will be required to support
the 25 basic training attendees and the 5 advanced training attendees?
How will the schedules be coordinated?

**Answer 2**: I believe 4 sessions +/- 1 should cover our needs.
Additional and more informal on site real application demo of software
and best practices is needed. Most users will be providing updates and
networks to the schedulers and project managers. So, this one-on-one is
for a select few (3-4) project managers.

**Question 3**: Are there any requirements for training duration and
syllabus sequence?

**Answer 3**: No, You should provide this in your response to the
solicitation.

**Question 4**: Does \"scheduling package\" refer to the Speed to Market
Concerto application? If not, what are the performance requirements for
the scheduling package?

**Answer 4**: Yes, We are interested in understanding/evaluating Speed
to Market for our Project Mgmt (PM) needs

**Question 5**: Is the vendor responsible for Concerto procurement? If
so, how many copies?

**Answer 5**: One seat (or minimum to provide training and demonstrate
implementation in SAB) + 1 year maintenance.

**Question 6**: Does LaRC have any special terms and conditions
regarding the scheduling package (e.g. maintenance, support,
compatibility, etc.)?

**Answer 6**: Must run on Windows2000

**Question 7**: Are there any other available data regarding this
solicitation other than the 2-page synopsis and 2-page statement of
work?

**Answer 7**: No

**Question 8**: The technical evaluation criteria for the scheduling
package appear to be representative of the features of Speed to
Market\'s Concerto application. Are these criteria intended to evaluate
the training delivery or an additional software package provided by the
vendor?

**Answer 8**: We would be happy to discuss another software package, but
at this time our focus is on Speed to market with this training. We have
not made a commitment to any software for the long term. Currently using
ProChain. Does not handle multiple projects in current version.
**1994 and 1862/1890 Cooperative Research Agreement**

**PROJECT
TITLE:**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

**1994
INSTITUTION:**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_**\_\_\_\_\_\_\_\_\_\_\_\_\_\_**

**1862 OR 1890
INSTITUTION:**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄

[Part I \-- TO BE Completed by the 1994 INSTITUTION:]{.smallcaps}

**A. DESCRIBE THE EXPECTED BENEFITS OF THE COOPERATIVE AGREEMENT FOR
YOUR INSTITUTION**

[(Explain how the project will help your institution attain its
goals)]{.smallcaps}**:**

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

(Signature of 1994 Project Director/Principal Investigator) (Date)

▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄

[Part II \-- To be Completed by the 1862 or 1890
Institution:]{.smallcaps}

**A. I HAVE REVIEWED THE TRIBAL COLLEGES RESEARCH GRANT PROPOSAL FOR THE
PROJECT LISTED ABOVE AND COMMIT MY INSTITUTION\'S SUPPORT FOR THE
PROJECT AS INDICATED:**

G [IDENTIFYING THE NEED FOR THE PROJECT]{.smallcaps} G [DEVELOPING A
CONCEPTUAL APPROACH]{.smallcaps}

> G [ASSISTING WITH PROJECT DESIGN]{.smallcaps} G [IDENTIFYING/SECURING
> RESOURCES]{.smallcaps}

G [DEVELOPING THE PROJECT BUDGET]{.smallcaps} G [PROMOTING INSTITUTIONAL
PARTNERSHIPS]{.smallcaps}

G [HELPING TO LAUNCH AND MANAGE THE PROJECT]{.smallcaps} G [PROVIDING
TECHNICAL ASSISTANCE]{.smallcaps}

G [PROVIDING CONSULTATION]{.smallcaps} G [PARTICIPATING IN PROJECT
EVALUATION]{.smallcaps}

G [DISSEMINATING FINAL PROJECT RESULTS]{.smallcaps} G [ENSURING PROJECT
SUCCESS IN OTHER WAYS]{.smallcaps}

G [PROVIDING ASSISTANCE AS NEEDED]{.smallcaps} G
[OTHER\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_]{.smallcaps}

**B. DESCRIBE THE EXPECTED BENEFITS OF THE COOPERATIVE AGREEMENT FOR
YOUR INSTITUTION** [(how the project will advance research collaboration
between the institution and the applicant, 1994 Land-grant
institution:]{.smallcaps}

**C. THE FOLLOWING PERSON(S) WILL SERVE AS MY INSTITUTION=S
LIAISON/CONTACT FOR THE PROJECT:**

> **NAME**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
> **PHONE**\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

(Signature of 1862 or 1890 Land-Grant AOR) (Date
**Updated 2007 Calendar of Events**

**Friends of Poe and Edgar Allan Poe National Historic Site**

***In the Master's Ghastly Grip***

A Park Ranger guides you through Poe's home, exploring Poe's themes of
terror.

Ocotber 13, 14, 20 and 21. 45 minutes. Free. 2:00 pm. Reservations
required. Call (215) 597-8780.

***Wedenesday, October 24, 2007*** Evening candlelight tours of the Poe
House featuring Poe and his tales of horror! This sellout event has
become a highlight of the season. Tours leave at 6:00, 6:30 and 7:00 PM.
\$10.00 per person but free for members of the Friends of Poe.
Reservations are required call (215) 861-4971. .

***Ongoing*** Looking for a little "terror of the soul"? The October
film series at the Colonial Theatre of Phoenixville, PA (yes, the
theater of "The Blob" fame) will focus on film versions of Poe's
stories. Admission is \$7.00 adult, \$6.00 Seniors & Students w/ID\
\$4 children). Showing Sundays at 2pm:

Oct 7 - The Black Cat (1934)

Oct 14 - The Raven (1935)

Oct 21 - The Fall of the House of Usher (1960) tentative --looking for a
35mm print\
Oct 28 - Masque of the Red Death (1964)\
Movie Info Line: 610-917-0223 and Theatre Offices:

610-917-1228 227

Bridge Street, Phoenixville, PA 19460\
website: www.thecolonialtheatre.com

***Saturday**, **October 27, 2007 8pm (doors open at 7:30) \$20*****.**
Don't miss this! The Glass Prism, from Scranton and Wilkes-Barre, PA,
who became successful with their 1969 RCA album, "Poe Through The Glass
Prism" and their hit single, "The Raven", will be performing live for
the Friends of Poe at the German Society, in Philadelphia, PA. They were
one of the originators of progressive concept-based rock, and have many
loyal fans to this day. Vinyl and CD's will be available for purchase.
Proceeds of this event will benefit the Friends of Poe. For tickets to
the event call 800-836-1691. Seating is limited so call now.

**January 2008** -- **Saturday, January 19,** 2008- Celebrate Edgar
Allan Poe's 199th birthday on the actual anniversary day! We will be
featuring recordings by various famous performers of Poe's poems and
stories. At 3:30 in the winter dusk, tour the house by candlelight. Free
but reservations suggested 215-597-8780, [www.nps.gov/inde]{.underline}.

We are planning for a wonderful celebration of Poe's Bicentennial in
2009.

Visit the Edgar Allan Poe National Historic Site on the

web at www.nps.gov/edal.
January 28, 2003

Gary J. Kauffman

Managing Member

Vortex Aviation Services, LLC

1946 Joe Crosson Drive

El Cajon, California 92020

Mr. Kauffmann;

This responds to your telephone inquiry regarding the transferability of
the existing air tour operator status under the National Park Air Tour
Management Act (the Act).

As we understand it, you would like to purchase an existing air tour
operator and thus obtain existing air tour operator status over a
national park. You have not informed us as to the name of this other
operator, its legal status, or the national park over which it has
operated.

It is the opinion of our office that whether you could purchase an
existing operator that had earned the right to fly over a national park
and obtain the right to fly over that park would depend 1) on the legal
status of the initial operator earning the status of existing operator;
and 2) on the nature of the business entity once the purchase was
complete.

First, a corporation is recognized by law as a person. Thus, if the
operator you wish to purchase was incorporated under the laws of a state
of the United States during the relevant time period preceding the
enactment of the Act, then the existing operator status belongs to the
corporation and would follow the corporation if ownership of that
corporation was transferred. Businesses organized as partnerships, or
sole proprietorships, however, do not survive as the same legal entities
when they are dissolved. Thus the existing operator status would be
extinguished upon the dissolution of the business and the existing
operator status could not be transferred.

If the operator you wish to purchase is a corporation, then the
corporation would retain its existing operator status in the event of a
transfer of ownership only if the corporation continued to exist as its
own legal person. The Act does not permit an existing operator

to transfer its existing operator status to another person. Thus only if
you purchase the entire corporation and have that corporation continue
to operate air tours in the park would you as the owner of the
corporation be able to take advantage of its existing operator status.
Once the corporation that earned the existing operator status ceases to
exist, the existing operator status would also cease to exist.

Please note that if you do purchase another carrier, please notify your
Principal Operations Inspector so that the appropriate amendments, if
any, can be made to the part 119 certificate to operate under part 135,
or to the operations specifications.

This opinion has been coordinated with the Office of Flight Standards,
AFS-200. I hope this opinion clarifies this issue for you. If you have
any questions, please call me at at 202-267-8893.

Sincerely,

Carol Moors Toth

Attorney Advisor,

Air Space and Operations Law Branch

Office of the Chief Counsel

Federal Aviation Administration
**PUBLIC NOTICE**![](media/image1.png){width="0.6541666666666667in"
height="0.6604166666666667in"}

**Federal Communications Commission**

**445 12th St., S.W.**

**Washington, D.C. 20554**

**October 20, 2000**

**CORRECTION TO COMMENT DUE DATES**

###### AUCTION OF LICENSES FOR THE 

# 700 MHz GUARD BANDS 

##### SCHEDULED FOR FEBRUARY 13, 2001

**COMMENT SOUGHT**

**ON RESERVE PRICES OR MINIMUM OPENING BIDS AND**

###### OTHER AUCTION PROCEDURAL ISSUES

**Report No. AUC-00-38-B (Auction No. 38)**

This *Public Notice* changes the comment and the reply comment dates for
*Public Notice* DA 00-2291 to October 27, 2000 and November 3, 2000,
respectively.

For further information concerning this proceeding, contact the Auctions
& Industry Analysis Division, Wireless Telecommunications Bureau, Howard
Davenport, Auctions Attorney, or Craig Bomberger, Auctions Analyst, at
(202) 418-0660; or Linda Sanderson, Project Manager, at (717) 338-2888.

-FCC-
**[FTA REGIONAL OFFICES]{.underline}**

The ten FTA Regional Offices listed below work with local transit
officials in developing and processing grant applications. For more
information about the FTA program in general, please contact the Office
of Public Affairs, Federal Transit Administration, 400 Seventh Street,
S.W., Washington, D.C., 20590 or call (202) 366-4043.

[Region 1]{.underline}

Connecticut, Massachusetts, Maine, New Hampshire, Rhode Island, and
Vermont.

FTA Region 1 Office, Kendall Square, 55 Broadway, Suite 920, Cambridge,
Massachusetts 02142-1093.

Telephone (617) 494-2055 Fax (617) 494-2865

[Region 2]{.underline}

New York, New Jersey, and Virgin Islands.

FTA Region 2 Office, One Bowling Green, Room 429, New York, New York
10004-1415.

Telephone (212) 668-2170 Fax (212) 668-2136

[Region 3]{.underline}

Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, and
West Virginia.

FTA Region 3 Office, 1760 Market Street, Suite 500, Philadelphia,
Pennsylvania 19103-4124.

Telephone (215) 656-7100 Fax (215) 656-7260 TDD (215) 656-7269

[Region 4]{.underline}

Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, Puerto
Rico, South Carolina, and Tennessee.

FTA Region 4 Office, Atlanta Federal Center, Suite 17T50, 61 Forsyth
St., SW, Atlanta, Georgia 30303.

Telephone (404) 562-3500 Fax (404) 562-3505

[Region 5]{.underline}

Illinois, Indiana, Minnesota, Michigan, Ohio, and Wisconsin.

FTA Region 5 Office, 200 W. Adams, Suite 320, Chicago, Illinois 60606.

Telephone (312) 353-2789 Fax (312) 886-0351

[Region 6]{.underline}

Arkansas, Louisiana, New Mexico, Oklahoma, and Texas.

FTA Region 6 Office, 819 Taylor Street, Room 8A36, Fort Worth, Texas
76102.

Telephone (817) 978-0550 Fax (817) 978-0575

[Region 7]{.underline}

Iowa, Kansas, Missouri, and Nebraska.

FTA Region 7 Office, 901 Locust Street, Room 404, Kansas City, Missouri
64106.

Telephone (816) 329-3920 Fax (816) 329-3921

[Region 8]{.underline}

Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming.

FTA Region 8 Office, 12300 West Dakota Ave., Suite 310, Lakewood,
Colorado 80228-2583.

Telephone (720) 963-3300 Fax (720) 963-3333

[Region 9]{.underline}

Arizona, California, Hawaii, Nevada, Guam, American Samoa and North
Marianas.

FTA Region 9 Office, 201 Mission Street, Suite 2210, San Francisco,
California 94105-1926.

Telephone (415) 744-3133 Fax (415) 744-2726

[Region 10]{.underline}

Alaska, Idaho, Oregon and Washington.

FTA Region 10 Office, 915 Second Avenue, Suite 3142, Seattle, Washington
98174-1002.

Telephone (206) 220-7954 Fax (206) 220-7959
PUBLIC NOTICE![](media/image1.png){width="0.6541666666666667in"
height="0.6604166666666667in"}

FEDERAL COMMUNICATIONS COMMISSION

445 12th STREET, S.W.

WASHINGTON, D.C. 20554

News media information 202/418-0500 Fax-On-Demand 202/418-2830 Internet:
http://www.fcc.gov ftp.fcc.gov

**Report No. 4112 April 22, 2008**

**MEDIA BUREAU ACTIONS**

The Commission, by its Media Bureau took the following actions on the
dates shown:

**ACTIONS OF: April 2, 2008**

**Ellington Broadcasting Dismissed, pursuant to § 0.283 of the
Commission's**

**WPRQ-LP Rules, must carry complaint filed December 12, 2007 against**

**CSR-7755-M Suddenlink Communications.**

**ACTIONS OF: April 3, 2008**

**NPG Cable, Inc. Dismissed, pursuant to § 0.283 of the Commission's**

**CSR-7109-Z Rules, Petition for Special Relief complaint filed**

**June 29, 2007.**

**ACTIONS OF: April 9, 2008**

**NEPSK, Inc. d/b/a Dismissed, pursuant to § 0.283 of the Commission's**

**Polaris Cable Services Rules, Petition for Limited Waiver of the ban
on**

**CSR-7294-Z integrated set-top boxes.**
GREENSBORO PIEDMONT TRIAD INTL (KGSO)

Calendar Day Extremes

Highest Maximum Temperature (degrees F)

Years: 1928-2005

Last updated: September 2005

  ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  Day   Jan   Feb   Mar   Apr   May   Jun   Jul   Aug   Sep   Oct   Nov   Dec

  1     75    73    75    85    92    95    98    97    105   90    85    72

  2     76    78    79    87    90    100   98    99    102   91    85    76

  3     72    79    82    90    92    98    97    98    99    91    84    72

  4     74    73    84    86    94    96    98    98    98    94    83    73

  5     71    72    81    89    92    96    98    96    97    95    81    74

  6     70    67    77    92    93    97    100   103   100   94    80    76

  7     71    71    81    93    93    94    101   99    98    92    78    78

  8     68    71    83    91    94    98    102   96    96    92    77    76

  9     70    69    81    90    91    99    101   95    99    91    80    73

  10    73    74    78    87    93    97    100   101   95    89    80    70

  11    70    80    86    93    90    95    98    96    96    86    80    70

  12    67    73    86    96    90    95    96    96    95    85    80    78

  13    73    73    85    88    91    96    98    97    94    88    83    72

  14    72    76    82    88    93    94    102   99    94    85    77    72

  15    77    78    87    88    92    95    97    96    92    87    81    73

  16    71    74    85    88    92    95    98    98    93    86    81    78

  17    76    76    90    90    92    98    97    99    98    84    78    68

  18    66    71    79    90    92    100   97    103   98    89    77    75

  19    70    74    84    90    94    100   98    99    93    86    76    78

  20    70    75    86    90    94    99    100   100   93    85    78    80

  21    72    74    89    90    96    100   99    100   96    85    79    65

  22    75    74    85    89    97    99    100   100   99    85    77    68

  23    73    73    81    90    96    97    99    99    99    86    76    69

  24    76    80    87    90    92    96    97    98    92    84    78    75

  25    75    84    88    91    94    101   97    97    95    85    79    74

  26    74    81    88    91    93    101   98    98    93    86    74    72

  27    72    76    84    90    95    102   99    97    90    87    74    71

  28    78    79    82    88    97    99    100   99    92    82    77    73

  29    78    77    86    88    98    99    101   103   89    82    75    74

  30    78    \-    85    87    96    101   99    104   89    83    74    76

  31    74    \-    86    \-    95    \-    99    105   \-    85    \-    67
  ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
**Disorder-Induced Resistive Anomaly Near Ferromagnetic Phase
Transitions\***

*Felix von Oppen*

*Freie Universitat Berlin*

We show that the resistivity *ρ(T)* of disordered ferromagnets near, and
above, the Curie temperature T~c~ generically exhibits a stronger
anomaly than the scaling-based Fisher-Langer prediction. Treating
transport beyond the Boltzmann description, we find that within
mean-field theory, *dρ/dT* exhibits a \|*T-T~c~*\|^-1/2^ singularity
near *T~c~*. Our results, being solely due to impurities, are relevant
to ferromagnets with low *T~c~*, such as SrRuO~3~ or diluted magnetic
semiconductors, whose mobility near *T~c~* is limited by disorder.

\*Carsten Timm, M. E. Raikh, Felix von Oppen, Phys. Rev. Lett. **94**,
036602 (2005).
Nonclinical Studies Subcommittee

of the Advisory Committee for Pharmaceutical Science

# Chair

John Doull, M.D., Ph.D.

Professor Emeritus of Pharmacology and Toxicology

Department of Pharmacology and Toxicology and Therapeutics

University of Kansas Medical Center

3901 Rainbow Boulevard

Kansas City, Kansas 66160-7417

**Executive Secretary**

Nancy Chamberlin, Pharm.D.

Advisors and Consultants Staff

Center for Drug Evaluation and Research

Food and Drug Administration (HFD-21)

5600 Fishers Lane

Rockville, Maryland 20857

\(301\) 827-7001 Fax: (301) 827-6776

Email: chamberlinn@cder.fda.gov

#### Consumer Representative

Gloria L. Anderson, Ph.D. 10/31/02

Fuller F. Callaway Professor of Chemistry

Morris Brown College

643 Martin Luther King Jr. Drive, NW

Atlanta, Georgia 30314-4140

**SGE Consultants**

Jay Goodman, Ph.D.

Professor of Pharmacology

Dept.of Pharmacology and Toxicology

Michigan State University

B-440 Life Sciences Bldg.

East Lansing, MI 48824-1317

## Joy Cavagnaro, Ph.D. 

P.O. Box 1362

Leesburg, VA 20177

##### Industry Participants

Jack H. Dean, Ph.D., D.A.B.T.

President and Scientific Director Sanofi-Synthelabo

Research Division

International Director Preclinical Development

Sanofi-Synthelabo, Inc.

9 Great Valley Parkway

Malvern, Pennsylvania 19355

Jack H. Reynolds, D.V.M.

Vice President, Drug Safety Evaluation

Pfizer, Inc.

Eastern Point Road

Groton, Connecticut 06340

4/5/01

**Government Participants**

David M. Essayan, M.D.

Food and Drug Administration

CBER/OTRR/DCTDA/PTB, HFM-579

Woodmont Building 1, Room 200 N

1401 Rockville Pike

Rockville, MD 20852

James T. MacGregor, Ph.D.

Deputy Director for Washington, NCTR

Parklawn, 16-53 HFT-10

5600 Fishers Lane

Rockville, MD 20857

Raymond Tennant, Ph.D.

National Institute of Environmental Health

Sciences/ NIH

101 Alexandar Drive

Research Triangle Park, NC 27709

Daniel A. Casciano, Ph.D.

Center Director, National Center Toxicology

NCTR

Building 13, Room 122, HFT-1

3900 NCTR Drive

Jefferson, Arkansas 72029

Helen N. Winkle

Acting Director, Office of Pharmaceutical Science

Food and Drug Administration

CDER/OPS/HFD-003

Woodmont Building 2, Room 6008

1451 Rockville Pike

Rockville, MD 20853
**U.S. Department of Labor** For Immediate
Release![](media/image1.png){width="6.479166666666667in"
height="0.75in"}

**Employee Benefits Security Administration** Date: February 10, 2003

Washington, D.C. Contact: Gloria Della

Release No.: 03-8 (202) 693-8664

**Labor Department Proposes Class Exemption**

# On Settlement of Litigation

**WASHINGTON--** The U.S. Department of Labor's Employee Benefits
Security Administration (EBSA) today proposed a class exemption to
facilitate the settlement of litigation by employee benefit plans with
related parties.

The employee benefit community raised questions as to whether plans that
release claims against related parties in exchange for cash violate the
prohibited transaction provisions of the Employee Retirement Income
Security Act (ERISA). The proposed exemption would allow plans to
release claims against related parties in exchange for cash. In
addition, the proposal would allow related parties to pay amounts owed
to plans on an installment basis.

Among the conditions of the proposal is the requirement that the terms
of the settlement be negotiated by a fiduciary not involved in the
transaction that was the subject of the litigation. The proposal should
remove any uncertainty and allow plan fiduciaries to properly carry out
their responsibilities under ERISA by focusing on the merits of the
settlement.

The proposed exemption is scheduled to be published in the Feb. 11, 2003
***Federal Register***. Questions or comments about the proposed
exemption should be directed to the Office of Exemption Determination at
202/693-8540.

\###

U.S. Labor Department releases are accessible on the Internet at
http://www.dol.gov/ebsa. The information in this news release will be
made available in alternate format upon request (large print, Braille,
audio tape or disc) from the COAST office. Please specify which news
release when placing your request. Call (202) 693-7773 or TTY (202)
693-3911.
**§42.24 Protective order.**

\(a\) A party or a prospective witness or deponent may file a motion for
a protective order with respect to discovery sought by an opposing party
or with respect to the hearing, seeking to limit the availability or
disclosure of evidence.

\(b\) In issuing a protective order, the ALJ may make any order which
justice requires to protect a party or person from annoyance,
embarrassment, oppression, or undue burden or expense, including one or
more of the following:

\(1\) That the discovery not be had;

\(2\) That the discovery may be had only on specified terms and
conditions, including a designation of the time or place;

\(3\) That discovery may be had only through a method of discovery other
than that requested;

\(4\) That certain matters not be inquired into, or that the scope of
discovery be limited to certain matters;

\(5\) That discovery be conducted with no one present except persons
designated by the ALJ;

\(6\) That the contents of discovery or evidence be sealed;

\(7\) That a deposition after being sealed be opened only by order of
the ALJ;

\(8\) That a trade secret or other confidential research, development,
commercial information, or facts pertaining to any criminal
investigation, proceeding, or other administrative investigation only be
disclosed in a designated way; or

\(9\) That the parties simultaneously file specified documents or
information enclosed in sealed envelopes to be opened as directed by the
ALJ.

**§42.25 Fees.**

The party requesting a subpoena shall pay the cost of the fees and
mileage of any witnesses subpoenaed in the amounts that would be payable
to a witness in a proceeding in United States District Court. A check
for witness fees and mileage shall accompany the subpoena when served,
except that when a subpoena is issued on behalf of the Department of
Veterans Affairs, a check for witness fees and mileage need not
accompany the subpoena.
**17.0 Preventive Action / Complaints and Corrective Action**

17.1 Preventive Action

1.  The laboratory participates in annual NTEP laboratory meetings.
    Discussion at these meetings includes the interpretation of type
    evaluation test procedures. The information from these meetings is
    documented and used to improve the quality of test in the
    laboratory. The laboratory obtains information from laboratory
    meetings and internal reviews and uses this information to examine
    its technical and quality system to identify needed improvements and
    potential sources of nonconformance. If preventive action is
    required, action plans are developed, implemented, and monitored.
    Procedures for preventive action are maintained in the laboratory
    (see Appendix H, AP No. 6).

\[NOTE: If the laboratory has a control chart process, this can be
referenced in this section as a means of preventive action\]

17.2 Complaints and Corrective Action

17.2.1 The laboratory promptly investigates complaints, adverse findings
during audits, or any other circumstance that raises doubts concerning
the laboratory\'s competence or compliance with required procedures. The
laboratory determines the root cause, identifies potential corrective
actions, and follows a corrective action procedure to resolve the
adverse situation promptly and, where necessary, conducts a retest.
Procedures for handling complaints are maintained in the laboratory (see
Appendix H, AP No. 6, AP No. 10, and AP No. 16).

2.  The laboratory quality manager examines all documents and records
    associated with complaints, and the laboratory technical manager
    investigates adverse audit findings and other circumstances. If
    deficiencies are discovered during these reviews, they are
    documented. After review of the deficiencies with the laboratory
    staff and management, corrective actions are documented for each
    deficiency appropriate to the magnitude and risk of that deficiency
    and likely to eliminate or prevent recurrence. Deadlines are set for
    each corrective action. The laboratory manager monitors the
    corrective action to ensure that it is effective (see Appendix H, AP
    No. 6).

3.  Records of deficiencies and corrective actions are maintained in the
    laboratory (see Section 13, Records and Appendix O, Forms).
X-ray Technicians -- Second survey

[Personal medical history of cancer]{.underline}

32. **Has a doctor ever told you that you had any type of CANCER?**

Ο No GO TO NEXT QUESTION

Ο Yes → Please mark "YES" for each type of cancer you have had diagnosed
by a doctor and specify the year of first [diagnosis]{.underline}.
Include only primary cancers, not those that originated from a different
site (i.e., do not list metastases).

**Mark here YEAR OF FIRST**

# PRIMARY CANCER for "Yes" DIAGNOSIS

↓

Bladder Ο → 19 \_\_\_\_\_

Bone Ο → 19 \_\_\_\_\_

Brain or Central Nervous system Ο → 19 \_\_\_\_\_

Breast Ο → 19 \_\_\_\_\_

Cervix (invasive) Ο → 19 \_\_\_\_\_

Colon Ο → 19 \_\_\_\_\_

Connective Tissue (Soft Tissue Sarcoma) Ο → 19 \_\_\_\_\_

Esophagus Ο → 19 \_\_\_\_\_

Hodgkin's Disease Ο → 19 \_\_\_\_\_

Kaposi's Sarcoma Ο → 19 \_\_\_\_\_

Kidney Ο → 19 \_\_\_\_\_

Larynx Ο → 19 \_\_\_\_\_

Leukemia, Acute Lymphocyic Ο → 19 \_\_\_\_\_

Leukemia, Chronic Lymphocytic Ο → 19 \_\_\_\_\_

Leukemia, Acute Myeloid

or Granulocytic Ο → 19 \_\_\_\_\_

Leukemia, Chronic Myeloid

or Granulocytic Ο → 19 \_\_\_\_\_

Leukemia, other than above or

type unknown Ο → 19 \_\_\_\_\_

Liver Ο → 19 \_\_\_\_\_

Lung or Bronchus Ο → 19 \_\_\_\_\_

Lymphoma, Non-Hodgkin's Ο → 19 \_\_\_\_\_

Lymphoma, type unknown Ο → 19 \_\_\_\_\_

Melanoma Ο → 19 \_\_\_\_\_

Multiple Myeloma Ο → 19 \_\_\_\_\_

Oral Cavity or Pharynx Ο → 19 \_\_\_\_\_

Ovary Ο → 19 \_\_\_\_\_

Pancreas Ο → 19 \_\_\_\_\_

Prostate Ο → 19 \_\_\_\_\_

Rectum Ο → 19 \_\_\_\_\_

Stomach Ο → 19 \_\_\_\_\_

Testis Ο → 19 \_\_\_\_\_

**Mark here YEAR OF FIRST**

# PRIMARY CANCER for "Yes" DIAGNOSIS

↓

Thyroid Ο → 19 \_\_\_\_\_

Uterus (endometrium) Ο → 19 \_\_\_\_\_

Skin, Basal Cell Carcinoma Ο → 19 \_\_\_\_\_

Skin, Squamous Cell Carcinoma Ο → 19 \_\_\_\_\_

Other cancer, specify below Ο → 19 \_\_\_\_\_

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Government-to-Government Consultation Requirements, based on Project
Type:

[Project Type:]{.underline} [GTG Required?]{.underline}

1\. Maintenance Grants No

2\. Equipment Acquisition No

3\. Master Plans Yes

4\. System Plans, varies based on Scope

a.  Area wide Transportation Plans Yes

b.  Area Borrow Site or Stockpiling Site Identification Yes

c.  Resource Inventories Yes

d.  Pavement Condition Index Inventories No

e.  Wildlife Hazard Assessments No (?)

f.  ALP Updates Yes, for new

> ALP

g.  Lighting: Edge Lighting No

h.  Others?

5\. Snow Removal Equipment Buildings

a\. On entirely previously disturbed land w/in Airport Prop. No

b\. Involves undisturbed land Yes

6\. Resurfacing Projects No

7\. New development or expansion, including w/in Airport Prop. Yes

8\. Connected Actions, consider for all development projects

e.g. Materials sources, haul routes, barge landings,

stockpile or storage areas

Connected Actions may necessitate GTG consultation for development
projects that are entirely on previously disturbed areas.
Joan Messina (217) 403-6248

**FINANCING QUALITY OF LIFE IN RURAL COMMUNITIES**

The lure of cities with all their amenities can make it challenging to
sustain rural populations and maintain the appealing rural life style.
Rural community leaders know that the vitality of their towns or
villages can depend on how well they meet the needs of their residents.
That means finding ways to provide essential services like quality
health care, good water, emergency services, internet access, and
libraries. Often the problem is finding a way to pay for these services.

USDA Rural Development was created to help take care of that problem.
The federal agency provides low cost financing for community facilities
and equipment in several ways. They provide loans directly to the
borrower. Current terms are about 4.5 percent interest for up to 40
years for 100 percent of the value of the facility. That translates into
a very affordable payment plan. The agency can also guarantee loans made
by private lenders. Guaranteed loans are a good tool for borrowing money
for very large projects. Limited grant funds area available for projects
in smaller, lower income areas.

The agency will work with borrowers on ways to repay the loans.
Nonprofits usually make payments from facility income. Public entities
can consider options such as facility income, debt certificates, general
funds, revenue bonds or tax levies.

Rural Development staff has worked with hundreds of non-profit
organizations, communities and other taxing bodies on thousands of
projects. Funds have been made available for equipment like rescue
equipment, emergency vehicles and electronic medical record software.
Recently funded facilities include fire stations, storm sirens, clinics,
libraries, community centers, group homes, day care and senior centers,
nursing homes, assisted living facilities, and hospitals.

Health care is a priority for rural areas and Rural Development as well
as a primary factor in attracting businesses and residents to a rural
community. Last November Salem Township Hospital broke ground for a
three-story addition financed with a \$6 million low cost Rural
Development loan. In March the doors opened to the Richland Memorial
Hospital's state-of-the-art obstetrics and gynecology unit. A \$4.4
million loan from Rural Development made it possible to purchase the
hospital from the county, and a \$2.8 million loan and \$1 million
guaranteed loan financed renovations to the existing hospital and the
new unit. These updated, modern facilities are expected to have a
substantial economic benefit in the counties they serve.

Plenty of funding is available through Rural Development. Last year
about \$52 million was used to finance community and infrastructure
projects in Illinois. The community provides the leadership and
commitment; Rural Development provides the access to capital.

More information on Rural Development community programs is available on
the web at [www.rurdev.usda.gov/il/](http://www.rurdev.usda.gov/il/) or
by calling any area U.S. Department of Agriculture Rural Development
office or the state office at (217) 403-6214.

\#
Coastal Ocean Research and Monitoring Program

Notice to Mariners

The UNCW Coastal Ocean Research and Monitoring Program (CORMP) is
seeking the co-operation of all mariners operating in Onslow Bay coastal
waters, just off of Wrightsville Beach. A low profile wave buoy was
deployed on 5/7/2008 approximately 5 miles from shore. The buoy provides
real-time wave data and water temperature for nearshore coastal waters.
This buoy is a 3 ft diameter sphere, with a yellow hull, and 8 ft
antennae. A yellow strobe is mounted to the top of the buoy hull and
flashes once every 5 seconds

![](media/image1.jpeg){width="3.3333333333333335in"
height="2.501388888888889in"}![](media/image2.jpeg){width="2.951388888888889in"
height="2.5701388888888888in"}

GPS Coordinates for Buoy: 34° 08.474\
77° 42.523

CORMP requests the assistance of the marine community in helping to
safeguard this buoy. There are a number of specific ways in which the
marine community can help.

-   **Never tie off to a buoy.** There are fragile instrumentation and
    antennas above and below the surface of the water, which are easily
    damaged, causing buoy failure.

-   **Give the buoys a wide berth to avoid entanglement of nets or other
    equipment in the subsurface mooring system.** Each buoy has a watch
    circle equal to approximately 2 times the water depth. Vessels
    towing nets, seismic or other equipment should stay at least 300
    yards from the buoy. All other vessels at least 50 yards.

-   **Call 1-910-962-2777 or 1-910-962-2331** if you notice a buoy
    damaged or drifting, or if you inadvertently entangle the mooring
    with your equipment.

-   Report any buoy damage to CORMP at the above phone number.
# **Ankle- Treatment**

**July 2006 OIG**

**Mr. Paul Stout**

# 

# Cochran Database of Systematic Reviews. 2 2006

Immobilization and functional treatment for acute later ankle ligament
injuries in adults

Here\'s the most detail I can get from the Cochran review.

Comparison:

1\. Between different forms of immobilization

2\. Between immobilization and physiotherapy

3\. Between immobilization and treatment

4\. Between immobilization and functional treatment

Only significant differences found between immobilization and functional
treatment

Functional treatments included bracing, elastic bandages, taping, and
softcast or wrap.

Return to Sports significantly shorter time with functional treatment.

Return to work at short-term follow-up significantly higher in
functional treatment group

No significant differences found for pain at any follow up time

Significantly fewer patients suffered from persistent swelling at
short-term follow up

No differences found in subjective feeling of giving way

Objective instability measured with Talar Tilt test or Anterior Drawer
test showed no difference at intermediate or long term follow up

No difference for ROM found

No significant difference for recurrent sprains

At intermediate follow up, significantly more patients were satisfied
with functional treatment
![](media/image1.png){width="5.991666666666666in" height="0.64375in"}

TO: Environmental Protection Agency

FROM: Program for Interagency Environmental Cooperation and 2008
Interagency Environmental Cooperation Class, at the University of
Houston EENR Center (Finalized by Professor Victor B. Flatt, A.L.
O'Quinn Chair in Environmental Law, University of Houston Law Center,
<vflatt@central.uh.edu>, 713-743-2155)

DATE: August 1, 2008

RE: Response to call for comments, issued on July 25, 2008, on Docket ID
No. EPA-HQ-OW-2008-0390

The Program for Interagency Environmental Cooperation, in conjunction
with the members of the 2008 Interagency Environmental Cooperation Class
at the University of Houston, both a part of the Center for Environment,
Energy, and Natural Resources Law, at the University of Houston Law
Center, are submitting the following comment on the EPA's proposed final
rule on regulation of Carbon Capture and Storage (CCS) under the Safe
Drinking Water Act (SDWA):

The EPA's proposed rule to regulate CO2 injection pursuant to the Safe
Drinking Water Act is well researched and thorough, and contains
important technical review and information for the effective storage and
regulation of storage facilities for CO2 streams. This rulemaking will
thus provide important regulatory consistency for CO2 capture,
injection, and storage, which will in turn facilitate further and more
efficient deployment of CCS technologies and projects.

However, we also believe that there are other barriers which may still
impede the deployment of CCS, which cannot be addressed through existing
legislative grants of power. Specifically, there are concerns governing
short and long term liability, ownership issues, state and tribal
sovereignty issues, and possible sequestration on the Outer Continental
Shelf. Therefore, the Program for Interagency Cooperation is proposing
legislation to address more of these barriers. It should be noted that
while the Program for Interagency Environmental Cooperation supports the
creation of new legislation to deal with CCS, much of the technical
requirements which would be determined by the EPA under such proposed
legislation are thoroughly addressed in this Proposed Rulemaking,
meaning that the work and research done here would be equally useful in
implementing the Program's Proposed Legislation.

Although the Call for Comments does not request legislative proposals,
we provide the entire proposed legislation and accompanying white paper
to provide context for evaluating whether this Proposed Final Rulemaking
should also spur additional legislative action. While we support the
Proposed Rule and the EPA moving forward with this Rule, the EPA also
has the authority to suggest and comment on proposed legislation that
furthers the agency's environmental protection mandates. (42 U.S.C. Sec.
7609). We believe that in addition to implementing the Proposed Rule,
that the EPA should also examine and suggest federal legislative changes
that would further reduce legal and regulatory barriers to the
deployment of CCS.
THIS PAGE LEFT BLANK INTENTIONALLY

ACTIVITY/MECHANISM BUDGET SUMMARY

Department of Health and Human Services

Indian Health Service - 75-0390-0-1-551

**Clinical Services**

[Program Authorization]{.underline}: Program authorized by 25 U.S.C. 13,
Snyder Act, and P.L. 83-568, Transfer Act 42 U.S.C. 2001.

+--------------+------------+-------------+-------------+-------------+
|              | 2002       | 2003        | 2004        | Increase    |
|              |            |             |             |             |
|              | [Actual]{. | President's | [Estimate]{ | [or         |
|              | underline} |             | .underline} | Decrease]{  |
|              |            | [Budget]{   |             | .underline} |
|              |            | .underline} |             |             |
+--------------+------------+-------------+-------------+-------------+
| BA           | \$1,8      | \$1,        | \$1,        | +\          |
|              | 91,434,000 | 945,125,000 | 987,146,000 | $42,021,000 |
+--------------+------------+-------------+-------------+-------------+
| FTE          | 7,856      | 7,938       | 7,948       | +10         |
+--------------+------------+-------------+-------------+-------------+
|              |            |             |             |             |
+--------------+------------+-------------+-------------+-------------+
| HIV-AIDS \$  | (\$        | (\          | (\          | (+49,000)   |
|              | 2,531,000) | $2,567,000) | $2,616,000) |             |
+--------------+------------+-------------+-------------+-------------+
| HIV-AIDS FTE | \(14\)     | \(14\)      | \(14\)      | \(0\)       |
+--------------+------------+-------------+-------------+-------------+
|              |            |             |             |             |
+--------------+------------+-------------+-------------+-------------+

**[Total Request Level]{.underline}** \-- The Total Request of
\$1,987,146,000 and 7,948 FTE is a net increase of \$42,021,000 and 10
FTE over the FY 2003 President\'s Budget request of \$1,945,125,000 and
7,938 FTE. The explanation of the request is described in the activities
that follow.
**APPENDIX A**

**COURSE ORDERING AND SUPPORT INFORMATION**

**COURSE ORDERING AND SUPPORT INFORMATION**

Intermediate Wildland Fire Behavior, S-290, is available for purchase
through:

National Interagency Fire Center

Attention: Great Basin Supply Office Cache

3833 South Development Avenue

Boise, Idaho 83705-5354

[Necessary components for presentation of the course]{.underline}:

> NFES 2890 Instructor Guide (one per instructor)
>
> NFES 2891 Student Workbook (one per student)
>
> NFES 2892 Course Materials CD-ROM
>
> NFES 2893 Student CD-ROM
>
> NFES 2894 *FLAME* Field Guide
>
> NFES 2165 Fireline Handbook Appendix B (PMS 410-1)
>
> (one per student)
>
> NFES 1574 Aids for Determining Fuel Models (PMS XXX)
>
> (one per student)
>
> NFES 1077 Incident Response Pocket Guide (PMS 461)
>
> (one per student)

[It is suggested that the Course Coordinator be familiar
with]{.underline}:

> NFES 2226 Course Coordinator's Guide

[Students will need:]{.underline}

-   Tables, chairs, pens, and pencils.

[Additional equipment for the instructors:]{.underline}

1\. Computer, projector, and a screen.

2\. White board with markers.

3\. Easel with extra flip chart pads and markers.
![](media/image1.png){width="0.6069444444444444in"
height="0.6131944444444445in"}**PUBLIC NOTICE**

**Federal Communications Commission** News media information 202 /
418-0500

**The Portals** Fax-On-Demand 202 / 418-2830

**445 Twelfth Street, S.W.** Internet: http://www.fcc.gov

**Washington, D.C. 20554** ftp.fcc.gov

**Report No.** **2573** **August 29, 2002**

###  PETITIONS FOR RECONSIDERATION OF ACTION IN RULEMAKING PROCEEDING

> Petitions for Reconsideration have been filed in the Commission\'s
> rulemaking proceeding listed in
>
> this Public Notice and published pursuant to 47 CFR Section 1.429(e).
> The full text of this document
>
> is available for viewing and copying in Room CY-A257, 445 12th Street,
> S.W., Washington, D.C. or
>
> may be purchased from the Commission\'s copy contractor, Qualex
> International (202) 863-2893.
>
> Oppositions to these petitions must be filed within 15 days of the
> date of public notice of the petition
>
> in the Federal Register. See Section 1.4(b)(1) of the Commission\'s
> rules (47 CFR 1.4(b)(1)). Replies
>
> to an opposition must be filed within 10 days after the time for
> filing oppositions has expired.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

> **Subject:** AMENDMENT OF THE COMMISSION'S RULES CONCERNING MARITIME
> COMMUNICATIONS (PR Docket No. 92-257, RM-9664)

**Filed By:** -John Reardon for Mobex Communications, Inc. on
08/23/2002\*

-Audrey P. Rasmussen, Attorney for Paging Systems, Inc. on 08/23/2002\*

-For Warren Havens and Telesaurus Holdings GB LLC, DBA LMS Wireless on
08/26/2002

-For Warren Havens and Telesaurus Holdings GB LLC, DBA LMS Wireless on
08/27/2002

\*Filed in accordance with Section 1.106(a)(1) of the Commission's
rules.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**FCC**
**John Harley, MD, PhD**

Oklahoma Medical Research Foundation

825 N.E. 13^th^ Street

Oklahoma, OK 73104

405.271.6673

john-harley@omrf.ouhsc.edu

Dr. John Harley received both his MD and PhD degrees from the University
of Pennsylvania, and is currently a Professor of Medicine and Professor
of Immunology at the University of Oklahoma Health Sciences Center. He
is also an Adjunct Professor in the Departments of Microbiology and
Pathology, and a Staff Physician with the U.S. Department of Veterans
Affairs Medical Center in Oklahoma City.

Dr. Harley's research interest is System lupus erythematosus (SLE). SLE
is a systemic autoimmune disease that most frequently affects young
women in their child-bearing years. His lab has been studying the immune
system and genetics of this disease in hopes that a deeper understanding
would lead to ways to prevent its sometimes tragic consequences.

When the immune system of a lupus patient develops an \"auto\" immune
response, it makes antibodies that focus the full wrath and force of the
human inflammatory system upon their own tissues and in essence promotes
self-destruction. Dr. Harley's group has studied the details of exactly
what these \"auto\" antibodies bind. This has led to the possibility
that lupus is an unusual consequence of the immune response against a
common virus, Epstein-Barr virus. This virus is known to cause
mononucleosis, head and neck cancer, and some forms of lymphoma.

On the other side of our laboratory, modern genetics has been applied to
study the tendency of lupus to occur in families. The Lupus Multiplex
Registry and Repository, a national collection of demographic,
diagnostic, clinical and genetic information, was assembled from a few
hundred families that have two or more members with lupus. the analyses
have identified more than 20 separate genetic effects and have helped
identify two of the potentially responsible genes.

Dr. Harley and his group also plan to use the knowledge and lessons
learned from their genetic studies research of lupus to build a similar
Sjögren's Syndrome (another autoimmune disorder) Registry and Repository
for the purpose of finding genetic association for this disease.
To BLM:

We must do all we can to preserve what little old growth remains in
western Oregon. The thousands of acres of sustainably farmed timber
resources in areas that have been repeatedly logged provide the jobs and
timber resources that can be utilized on a sustainable basis. Have we
not learned anything from the destruction of natural habitats around the
world? It has been scientifically proven that the destruction of forest
habitat (especially rainforest....yes we live in a temperate rainforest)
has contributed significantly to world wide climate change. It would be
a sin and a crime to see what little remains of Oregon's ancient forest
heritage to be squandered for short sighted financial gains instead of
leaving it as a legacy for our children's children while helping to
insure a future of clean water, air and a healthy eco-system for all of
us

I'm a documentary filmmaker and have seen first hand from the Amazon to
the Yangtze what health, social and environmental problems emerge when
the ecosystem is not managed with respect and care for ts natural
systems. We MUST do our part to be accountable for the survival of our
fractured eco-systems world wide, starting right here at home.
Ultimately our own survival depends on it.

Spence Palermo